Weblink Global Medical Isotope Production Market CAGR To Be 8.29% (openpr.com)Press releaseGlobal Medical Isotope Production Market CAGR To Be 8.29% by 2040, Due To the Growing Demand for Medical Isotopes in Diagnostic and Therapeutic Procedures| Roots Analysis
According to our latest market report "Global Medical Isotope Production Market, Till 2040 by "Scale of Operation, Type of Isotope, Radioisotope, Production Method, Application Area, Type of Diagnostic Radioisotope, Type of Therapeutic Radioisotope, Therapeutic Area, End Users, Geographical Regions and Leading Players", the global medical isotope production market size is projected to reach USD 15.06 billion by 2040 from USD 4.56 billion in 2025, growing at a CAGR of 8.29% in the forecast period.
To request quote of this report, please visit: https://www.rootsanalysis.com/reports/medical-isotope-production-market/request-quote.html
In the era of modern medicine, medical isotopes have emerged as a promising and advanced nuclear medicine solution that can be used for the diagnosis and treatment of various chronic conditions. Notably, nuclear medicine involves the use of radioisotopes in combination with biological molecules that target specific cells, tissues or organs within the human body. Currently, nuclear reactors and particle accelerators / cyclotrons are being actively used to produce a wide array of medical isotopes for both diagnostic and therapeutic applications. However, as the demand for isotopes grows, so does the need for more advanced and efficient production technologies. As a result, several partnerships and collaborations have been established by stakeholders in medical isotope domain; enabling companies to expand their respective product portfolios and enhance their capabilities and visibility in this domain.
- Forums
- ASX - By Stock
- TLX
- Telix ASX TLX Breaking News & Current Commentary
TLX
telix pharmaceuticals limited
Add to My Watchlist
1.17%
!
$24.44

Telix ASX TLX Breaking News & Current Commentary, page-3170
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$24.44 |
Change
-0.290(1.17%) |
Mkt cap ! $8.270B |
Open | High | Low | Value | Volume |
$25.24 | $25.27 | $24.44 | $18.19M | 739.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 3936 | $24.42 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$24.56 | 1820 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 3936 | 24.420 |
1 | 3330 | 24.410 |
2 | 1950 | 24.400 |
2 | 8444 | 24.370 |
1 | 1815 | 24.350 |
Price($) | Vol. | No. |
---|---|---|
24.560 | 1820 | 1 |
24.580 | 1850 | 1 |
24.590 | 1122 | 1 |
24.610 | 4730 | 3 |
24.650 | 4266 | 3 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online